KALRN and schizophrenia: Kalirin has been implicated in a variety of neuropsychiatric and neurodegenerative diseases like schizophrenia, depression and Alzheimer’s disease (Hill et al., 2006; Mandela and Ma, 2012; Remmers et al., 2014; Makrythanasis et al., 2016).